Serial Number 98253493
730

Registration Progress

Application Filed
Nov 3, 2023
Under Examination
Sep 17, 2024
Approved for Publication
Jul 23, 2024
Published for Opposition
Jul 23, 2024
Registered

Trademark Image

Basic Information

Serial Number
98253493
Filing Date
November 3, 2023
Published for Opposition
July 23, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
730
Status Date
Mar 17, 2025
Application
Pending
Classes
005 042

Rights Holder

Diakonos Oncology Corporation

03
Address
1110 NASA Parkway, Ste. 108i
Houston, TX 77058

Ownership History

Diakonos Oncology Corporation

Original Applicant
03
Houston, TX

Diakonos Oncology Corporation

Original Applicant
03
Houston, TX

Diakonos Oncology Corporation

Owner at Publication
03
Houston, TX

Diakonos Oncology Corporation

Owner at Publication
03
Houston, TX

Legal Representation

Attorney
Andrea Shannon

Application History

26 events
Date Code Type Description Documents
Mar 18, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 18, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 17, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 17, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 17, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 17, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 17, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 17, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 17, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 17, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 17, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 17, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 13, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 13, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 22, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 22, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 21, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 21, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 7, 2023 NWAP I NEW APPLICATION ENTERED Loading...
Nov 7, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use consisting of immunotherapy agents for the treatment and prevention of cancer; vaccine preparations
Class 042
Providing medical research and scientific research information in the field of oncology; medical research in the field of oncology; research and development of immunotherapy drugs

Additional Information

Design Mark
The mark consists of 2 crosses inside a shaded circle.
Design Mark
The mark consists of 2 crosses inside a shaded circle.
Color Claim
Color is not claimed as a feature of the mark.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042